UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

Whole-pelvis, “mini-pelvis,” or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.647-653

2006

Link zum Volltext

Verfügbarkeit prüfen

Validity of Current Stereotactic Body Radiation Therapy Dose Constraints for Aorta and Major Vessels

Seminars in radiation oncology, 2016-04, Vol.26 (2), p.135-139

2016

Link zum Volltext

Verfügbarkeit prüfen

Small Bowel Dose Tolerance for Stereotactic Body Radiation Therapy

Seminars in radiation oncology, 2016-04, Vol.26 (2), p.157-164

2016

Link zum Volltext

Verfügbarkeit prüfen

Introduction and Clinical Overview of the DVH Risk Map

Seminars in radiation oncology, 2016-04, Vol.26 (2), p.89-96

2016

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic Body Radiotherapy as an Alternative to Brachytherapy in Gynecologic Cancer

BioMed research international, 2013-01, Vol.2013, p.898953-6

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase III Multi-Institutional Trial of Adjuvant Chemotherapy With Paclitaxel, Estramustine, and Oral Etoposide Combined With Long-Term Androgen Suppression Therapy and Radiotherapy Versus Long-Term Androgen Suppression Plus Radiotherapy Alone for High-Risk Prostate Cancer: Preliminary Toxicity Analysis of RTOG 99-02

International journal of radiation oncology, biology, physics, 2009-03, Vol.73 (3), p.672-678

2009

Link zum Volltext

Verfügbarkeit prüfen

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials

International journal of radiation oncology, biology, physics, 2000-06, Vol.47 (3), p.617-627

2000

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of p16 in Locally Advanced Prostate Cancer: A Study Based on Radiation Therapy Oncology Group Protocol 9202

Journal of clinical oncology, 2007-07, Vol.25 (21), p.3082-3089

2007

Link zum Volltext

Verfügbarkeit prüfen

The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02

Clinical cancer research, 2009-09, Vol.15 (17), p.5478-5484

2009

Link zum Volltext

Verfügbarkeit prüfen

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31

International journal of radiation oncology, biology, physics, 2005-04, Vol.61 (5), p.1285-1290

2005

Link zum Volltext

Verfügbarkeit prüfen

Volume effects in radiosurgical spinal cord dose tolerance: how small is too small?

Journal of radiation oncology, 2019-03, Vol.8 (1), p.53-61

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of Surgical Staging in Evaluating the Radiotherapeutic Outcome in RTOG 77-06, a phase III Study for T1BN0M0 (A 2) and T2N0M0 (B) Prostate Carcinoma

International journal of radiation oncology, biology, physics, 1998-03, Vol.40 (4), p.769-782

1998

Link zum Volltext

Verfügbarkeit prüfen

Clinical evidence for dose tolerance of the central nervous system in hypofractionated radiotherapy

Journal of radiation oncology, 2018-12, Vol.7 (4), p.293-305

2018

Link zum Volltext

Verfügbarkeit prüfen

Low toxicity for lung tumors near the mediastinum treated with stereotactic body radiation therapy

Practical Radiation Oncology, 2013-04, Vol.3 (2), p.130-137

2013

Link zum Volltext

Verfügbarkeit prüfen

The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41 (2), p.207-214

2003

Link zum Volltext

Verfügbarkeit prüfen

Race and Survival of Men Treated for Prostate Cancer on Radiation Therapy Oncology Group Phase III Randomized Trials

The Journal of urology, 2003, Vol.169 (1), p.245-250

2003

Link zum Volltext

Verfügbarkeit prüfen

Racial differences in prostate cancer related to loss of heterozygosity on chromosome 8p12–23

International journal of radiation oncology, biology, physics, 1999-11, Vol.45 (4), p.835-840

1999

Link zum Volltext

Verfügbarkeit prüfen

Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients

Cancer research (Chicago, Ill.), 1996-06, Vol.56 (12), p.2827-2831

1996

Link zum Volltext

Verfügbarkeit prüfen

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706

International journal of radiation oncology, biology, physics, 1991-09, Vol.21 (4), p.935-939

1991

Link zum Volltext

Verfügbarkeit prüfen

Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC)

International journal of radiation oncology, biology, physics, 1998-09, Vol.42 (2), p.263-267

1998

Link zum Volltext

Verfügbarkeit prüfen

Irradiation with or without misonidazole for patients with stages IIIb and IVa carcinoma of the cervix: final results of RTOG 80-05

International journal of radiation oncology, biology, physics, 1999-06, Vol.44 (3), p.513-517

1999

Link zum Volltext

Verfügbarkeit prüfen

Phase II prospective study of radiosurgery for multiple CNS metastatic disease

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e20555-e20555

2015

Link zum Volltext

Verfügbarkeit prüfen

Prostate-specific antigen and androgens in African-American and white normal subjects and prostate cancer patients

Journal of the National Medical Association, 2000-09, Vol.92 (9), p.445-449

2000

Link zum Volltext

Verfügbarkeit prüfen

Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on radiation therapy oncology group clinical trials

International journal of radiation oncology, biology, physics, 2000-06, Vol.47 (3), p.609-615

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(78)

Sprache

Englisch
(78)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Humans
(51)
Life Sciences & Biomedicine
(48)
Science & Technology
(48)
Oncology
(40)
Male
(39)
Biological And Medical Sciences
(31)
Medical Sciences
(31)
Radiology, Nuclear Medicine & Medical Imaging
(30)
Middle Aged
(29)
Aged
(27)
Female
(23)
Radiotherapy
(17)
Prognosis
(16)
Prostate Cancer
(15)
Radiotherapy Dosage
(15)
Prostatic Neoplasms - Radiotherapy
(14)
Combined Modality Therapy
(13)
Survival Rate
(12)
Adult
(11)
Survival Analysis
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Whole-pelvis, “mini-pelvis,” or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial

Validity of Current Stereotactic Body Radiation Therapy Dose Constraints for Aorta and Major Vessels

Potential Clinical Significance of Overall Targeting Accuracy and Motion Management in the Treatment of Tumors That Move With Respiration: Lessons Learnt From a Quarter Century of Stereotactic Body Radiotherapy From Dose Response Models

Small Bowel Dose Tolerance for Stereotactic Body Radiation Therapy

Introduction and Clinical Overview of the DVH Risk Map

Stereotactic Body Radiotherapy as an Alternative to Brachytherapy in Gynecologic Cancer

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials

Prognostic Value of p16 in Locally Advanced Prostate Cancer: A Study Based on Radiation Therapy Oncology Group Protocol 9202

The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31

Volume effects in radiosurgical spinal cord dose tolerance: how small is too small?

Impact of Surgical Staging in Evaluating the Radiotherapeutic Outcome in RTOG 77-06, a phase III Study for T1BN0M0 (A 2) and T2N0M0 (B) Prostate Carcinoma

Clinical evidence for dose tolerance of the central nervous system in hypofractionated radiotherapy

Low toxicity for lung tumors near the mediastinum treated with stereotactic body radiation therapy

The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data

Race and Survival of Men Treated for Prostate Cancer on Radiation Therapy Oncology Group Phase III Randomized Trials

Racial differences in prostate cancer related to loss of heterozygosity on chromosome 8p12–23

Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706

Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC)

Irradiation with or without misonidazole for patients with stages IIIb and IVa carcinoma of the cervix: final results of RTOG 80-05

Phase II prospective study of radiosurgery for multiple CNS metastatic disease

Prostate-specific antigen and androgens in African-American and white normal subjects and prostate cancer patients

Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on radiation therapy oncology group clinical trials

Suchergebnisse filtern